This study looks at whether a special group of doctors and scientists, called a Genomic Tumor Board (GTB), can help more cancer patients get treatments based on their genetic information. Genomic tumor tests are used to find out important details about a person's cancer by looking at their genes. In this study, some patients will have their test results reviewed by a GTB, while others will not. The GTB gives extra advice based on the test results to help doctors choose the best treatment. This study will help find out if having a GTB makes it easier for doctors to understand and use these test results effectively.
- Study Duration: Patients are followed for up to 24 months.
- Visits: Virtual GTB meetings occur weekly.
- Eligibility: Patients with advanced cancer and specific genomic tests are eligible.
By participating, patients might receive treatments tailored to their genetic makeup, potentially improving outcomes. However, joining the study also means following specific guidelines and schedules. Participants must sign informed consent to be part of the study.